Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

ClinicalTrials.gov ID: NCT02542696

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02542696. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Study identification

NCT ID
NCT02542696
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
496 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2015 (Actual)
Primary completion
Nov 8, 2022 (Actual)
Completion
Nov 8, 2022 (Actual)
Last update posted
Nov 22, 2023

2015 – 2022

United States locations

U.S. sites
48
U.S. states
24
U.S. cities
45
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35233 —
Muhammed Ali Parkinson and Movement Disorder Center/Barrow Neurological Institute Phoenix Arizona 85013 —
Movement Disorders Center of Arizona Scottsdale Arizona 85258 —
Clinical Trials, Inc. Little Rock Arkansas 72205 —
The Parkinson's and Movement Disorder Institute Fountain Valley California 92708 —
UC Irvine Health Gottschalk Medical Plaza Irvine California 92697 —
Keck Medical Center at USC Los Angeles California 90033 —
University of Colorado School of Medicine Aurora Colorado 80045 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Parkinsons Disease and Movement Disorders Center Boca Raton Florida 33486 —
University of Miami, Miller School of Medicine Miami Florida 33136 —
Parkinson's Disease Treatment Center of Southwest Florida Port Charlotte Florida 33980 —
Suncoast Neuroscience Associates Inc. St. Petersburg Florida 33713 —
USF Parkinson's Disease and Movement Disorder Center Tampa Florida 33613 —
Emory University Department of Neurology Atlanta Georgia 30329 —
GRU Movement Disorders Augusta Georgia 30912 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
NorthShore Neurological Institute B043D Glenview Illinois 60026 —
Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center Winfield Illinois 60190 —
University of Iowa Dept. of Neurology Iowa City Iowa 52242 —
Kansas University Medical Center-Department of Neurology Kansas City Kansas 66160 —
University of Kentucky Lexington Kentucky 40536 —
University of Maryland Baltimore Maryland 21201 —
Johns Hopkins University Baltimore Maryland 21287 —
Michigan State University - Dept. of Neurology East Lansing Michigan 48824 —
QUEST Research Institute Farmington Hills Michigan 48334 —
Henry Ford Hospital West Bloomfield Michigan 48322 —
Park Nicolet Institute - Stuthers Parkinson's Center Golden Valley Minnesota 55427 —
SUNY Downstate Medical Center, Department of Neurology Brooklyn New York 11203 —
Bendheim Parkinson's and Movement Disorder Center (Mount Sinai Medical Center) New York New York 10029 —
Columbia University Medical Center - Neurological Institute, Movement Disorders New York New York 10032 —
Duke University - Movement Disorders Clinic Durham North Carolina 27705 —
Raleigh Neurology Associates, P.A. Raleigh North Carolina 27607 —
Wake Forest Baptist Health Winston-Salem North Carolina 27157 —
University of Cincinnati Cincinnati Ohio 45219 —
Cleveland Clinic Cleveland Ohio 44195 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
UT Gardner-McMaster Parkinson's Center Toledo Ohio 43614 —
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136 —
Jefferson University Hospital Philadelphia Philadelphia Pennsylvania 19107 —
Medical University of South Carolina Charleston South Carolina 29425 —
Houston Methodist Neurological Institute Houston Texas 77030 —
East Texas Medical Center Tyler Texas 75701 —
University of Virginia Adult Neurology Charlottesville Virginia 322903 —
Sentara Neuroscience Institute Virginia Beach Virginia 23456 —
Evergreen Health Kirkland Washington 98034 —
Swedish Neuroscience Research Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02542696, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2023 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.